Quantcast CELLCT BIOMD SP ADS Stock Quote | Stock Price for APOP | Financial News | myMotherLode.com

Financial News

Motherlode Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
CELLCT BIOMD SP ADS (NQ: APOP)
7.160 USD  -0.010 (-0.14%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jun 22, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 5,660
Open 7.200
Bid (Size) 7.070 (1400)
Ask (Size) 7.960 (3000)
Prev. Close 7.170
Today's Range 7.130 - 7.200
52wk Range 6.120 - 11.38
Shares Outstanding 6,509,639
Dividend Yield N/A
Performance
YTD
-7.61%
-7.61%
1 Month
+2.87%
+2.87%
3 Month
+1.56%
+1.56%
6 Month
+1.42%
+1.42%
1 Year
-14.25%
-14.25%
Top News
More News
Cellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2018 Financial Results
Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results... Read More
from PR Newswire
Former GE Healthcare Executive to Join Cellect as Chief Business Officer
Andrew Sabatier, formerly the US Sales and Market Development Leader for GE Cell Therapy, will be heading up the commercialization of Cellect Apograft™ technology, as well as new business development. Read More
from PR Newswire
More News
Read More
Cellect Announces a Major Milestone for Enabling Stem Cells Production
from PR Newswire
Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
from PR Newswire
Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged
from PR Newswire
Cellect Biotechnology Announces $4 Million Registered Direct Offering
from PR Newswire
Cellect Announces Opening of a Second Clinical Trial Site and Approval from Safety Board (DSMB) for Dose Escalation
from PR Newswire
Benzinga Pro's 5 Stocks To Watch Today
category News , Benzinga , MNLO , and 6 more.
from Benzinga
BRIEF-Cellect Biotechnology Successfully Completed Proof Of Concept Testing For First Scalable Production Of Apotainer
category companyNews
from Reuters: Company News
BRIEF-Cellect Biotechnology Announces $4 Mln Registered Direct Offering
category companyNews
from Reuters: Company News
7 Stocks Moving In Tuesday's After-Hours Session
category TVTY , VOXX , Movers , and 9 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Follow myMotherLode.com at these social networks Make Us Your Homepage Today Follow us on Facebook Follow us on Twitter Follow us on Youtube Follow us on LinkedIn Follow our RSS Feed
Yellow Pages

Popular Searches

Local Radio Stations
© Copyright 2000-2017 Clarke Broadcasting Corporation. All rights reserved.